Cellectar Initiates Cohort 6 of Phase 1b Trial Evaluating CLR 131 in Relapsed/Refractory Multiple Myeloma

Author's Avatar
Dec 04, 2018
Article's Main Image

Patient enrolled at highest fractionated two-dose regimen to date